Table of Content - Global And China Osteoporosis Drugs Market

Osteoporosis is characterized by reduction in the density and quality of bones that often result in broken bones in the wrist, hip, and spine. Various factors responsible for osteoporosis include, genetic factors, low intake of calcium, magnesium, and vitamin D, eating disorders such as anorexia, inactivity and immobility, and excessive alcohol intake. Increasing approvals and launches of novel osteoporosis drugs along with increasing prevalence of osteoporasis is expected to significantly drive the osteoporosis treatment market growth over forecast period.

Key features of the study:

This report provides in-depth analysis of the Global and China Osteoporosis Drugs Market and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global and China Osteoporosis Drugs Market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Merck & Co., Eli Lilly, Procter & Gamble, Enzo Biochem, Inc., Sanofi-Aventis, Novartis, Wyeth, Roche, GlaxoSmithKline, UCB, Amgen, BeiGene Co., Ltd., Bone Biologics, Teijin Pharma Limited, JHL Biotech Inc., Keros Therapeutics, and Taro Pharmaceuticals Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global and China Osteoporosis Drugs Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global and China Osteoporosis Drugs Market

Detailed Segmentation:

Global and China Osteoporosis Drugs Market, By Drug Type:
- Bisphosphonates
  - Alendronate
  - Risedronate
  - Ibandronate
  - Zoledronic Acid
  - Others
- Calcitonin
- Hormone Therapy
- Selective Estrogen Receptor Modulators (SERMs)
- Parathyroid Hormone-Related Protein (PTHrP) Analog
- Rank Ligand (RANKL) Inhibitor
Global and China Osteoporosis Drugs Market, By Route of Administration:
- Oral
- Injectable
- Others
Global and China Osteoporosis Drugs Market, By Distribution Channel:
- Hospitals Pharmacies
- Online Pharmacies
- Retail Pharmacies
Global and China Osteoporosis Drugs Market, By Region:
- North America
  - By Drug Type:
    - Bisphosphonates
      - Alendronate
      - Risedronate
      - Ibandronate
      - Zoledronic Acid
      - Others
    - Calcitonin
    - Hormone Therapy
    - Selective Estrogen Receptor Modulators (SERMs)
    - Parathyroid Hormone-Related Protein (PTHrP) Analog
    - Rank Ligand (RANKL) Inhibitor
  - By Route of Administration
    - Oral
    - Injectable
    - Others
  - By Distribution Channel
    - Hospitals Pharmacies
    - Online Pharmacies
    - Retail Pharmacies
  - By Country
    - U.S.
    - Canada
- Latin America
  - By Drug Type:
    - Bisphosphonates
      - Alendronate
      - Risedronate
      - Ibandronate
      - Zoledronic Acid
      - Others
    - Calcitonin
    - Hormone Therapy
    - Selective Estrogen Receptor Modulators (SERMs)
    - Parathyroid Hormone-Related Protein (PTHrP) Analog
    - Rank Ligand (RANKL) Inhibitor
  - By Route of Administration
    - Oral
    - Injectable
    - Others
  - By Distribution Channel
    - Hospitals Pharmacies
    - Online Pharmacies
    - Retail Pharmacies
  - By Country
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Drug Type:
    - Bisphosphonates
      - Alendronate
      - Risedronate
      - Ibandronate
      - Zoledronic Acid
      - Others
    - Calcitonin
    - Hormone Therapy
    - Selective Estrogen Receptor Modulators (SERMs)
    - Parathyroid Hormone-Related Protein (PTHrP) Analog
    - Rank Ligand (RANKL) Inhibitor
  - By Route of Administration
    - Oral
    - Injectable
    - Others
  - By Distribution Channel
    - Hospitals Pharmacies
    - Online Pharmacies
    - Retail Pharmacies
  - By Country
    - U.K.
    - Germany
    - France
    - Spain
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Drug Type:
    - Bisphosphonates
      - Alendronate
      - Risedronate
      - Ibandronate
      - Zoledronic Acid
      - Others
    - Calcitonin
    - Hormone Therapy
    - Selective Estrogen Receptor Modulators (SERMs)
    - Parathyroid Hormone-Related Protein (PTHrP) Analog
    - Rank Ligand (RANKL) Inhibitor
  - By Route of Administration
    - Oral
    - Injectable
    - Others
  - By Distribution Channel
    - Hospitals Pharmacies
    - Online Pharmacies
    - Retail Pharmacies
  - By Country
    - Japan
    - India
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- China
  - By Drug Type:
    - Bisphosphonates
      - Alendronate
      - Risedronate
      - Ibandronate
      - Zoledronic Acid
      - Others
    - Calcitonin
    - Hormone Therapy
    - Selective Estrogen Receptor Modulators (SERMs)
    - Parathyroid Hormone-Related Protein (PTHrP) Analog
    - Rank Ligand (RANKL) Inhibitor
  - By Route of Administration
    - Oral
    - Injectable
    - Others
  - By Distribution Channel
    - Hospitals Pharmacies
    - Online Pharmacies
    - Retail Pharmacies
- Middle East
  - By Drug Type:
    - Bisphosphonates
      - Alendronate
      - Risedronate
      - Ibandronate
      - Zoledronic Acid
      - Others
    - Calcitonin
    - Hormone Therapy
    - Selective Estrogen Receptor Modulators (SERMs)
    - Parathyroid Hormone-Related Protein (PTHrP) Analog
    - Rank Ligand (RANKL) Inhibitor
  - By Route of Administration
    - Oral
    - Injectable
    - Others
  - By Distribution Channel
    - Hospitals Pharmacies
    - Online Pharmacies
    - Retail Pharmacies
  - By Country
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - By Drug Type:
    - Bisphosphonates
      - Alendronate
      - Risedronate
      - Ibandronate
      - Zoledronic Acid
      - Others
    - Calcitonin
    - Hormone Therapy
    - Selective Estrogen Receptor Modulators (SERMs)
    - Parathyroid Hormone-Related Protein (PTHrP) Analog
    - Rank Ligand (RANKL) Inhibitor
  - By Route of Administration
    - Oral
    - Injectable
    - Others
  - By Distribution Channel
    - Hospitals Pharmacies
    - Online Pharmacies
    - Retail Pharmacies
  - By Country
    - North Africa
    - Central Africa
    - South Africa
Company Profiles
- Merck & Co. *
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Eli Lilly
- Procter & Gamble
- Enzo Biochem, Inc.
- Sanofi-Aventis
- Novartis
- Wyeth
- Roche.
- GlaxoSmithKline
- UCB
- Amgen
- BeiGene Co., Ltd.
- Bone Biologics
- Teijin Pharma Limited
- JHL Biotech Inc.
- Keros Therapeutics
- Taro Pharmaceuticals Inc.
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drug Type
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
Global and China Osteoporosis Drugs Market– COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
Global and China Osteoporosis Drugs Market, By Drug Type, 2018–2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Bisphosphonates
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
    - Alendronate
    - Risedronate
    - Ibandronate
    - Zoledronic Acid
    - Others
- Calcitonin
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
- Hormone Therapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
- Selective Estrogen Receptor Modulators (SERMs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
- Parathyroid Hormone-Related Protein (PTHrP) Analog
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
- Rank Ligand (RANKL) Inhibitor
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
Global and China Osteoporosis Drugs Market, By Route of Administration, 2018–2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
- Injectable
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
Global and China Osteoporosis Drugs Market, By Distribution Channel, 2018–2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
Global and China Osteoporosis Drugs Market, By Region, 2018–2030, (US$ Bn)
- Introduction
  - Market Share Analysis, By Region, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Regions, 2018–2030
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- China
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018- 2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Lilly
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Procter & Gamble
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Enzo Biochem Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Wyeth Nutrition (A subsidiary of Pfizer Inc.)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Hoffmann-La Roche Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSP plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- UCB S.A.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Amgen Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- BeiGene, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bone Biologics Corp
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- TEIJIN LIMITED
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Eden Biologics (Formerly known as JHL Biotech Inc.)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Keros Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Taro Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

*Browse 34 market data tables and 33 figures on “Osteoporosis Drugs Market”- Global and China forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount